Genmab
GMAB
#1442
Rank
NZ$21.60 B
Marketcap
$34.02
Share price
-0.62%
Change (1 day)
-26.29%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2023 (TTM): $1.70

According to Genmab's latest financial reports the company's current EPS (TTM) is $1.77. In 2022 the company made an earnings per share (EPS) of $2.05 an increase over its 2021 EPS that were of $1.26.

EPS history for Genmab from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.70-17.15%
2022$2.0562.07%
2021$1.26-35.78%
2020$1.97119.14%
2019$0.9036.35%
2018$0.6629.83%
2017$0.510.92%
2016$0.5047.69%
2015$0.34109.32%
2014$0.16134.03%
2013$0.06941-121.08%
2012-$0.33-23.69%
2011-$0.4394.77%
2010-$0.22-70.48%
2009-$0.75